ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 212 filers reported holding ALKERMES PLC in Q4 2020. The put-call ratio across all filers is 5.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,762,644 | -9.7% | 991,169 | +0.9% | 0.32% | -0.3% |
| Q2 2023 | $30,755,913 | +110262.8% | 982,617 | -0.6% | 0.32% | +7.0% |
| Q1 2023 | $27,868 | +108.6% | 988,587 | +93.4% | 0.30% | +102.0% |
| Q4 2022 | $13,358 | -99.9% | 511,235 | +14.7% | 0.15% | +25.2% |
| Q3 2022 | $9,952,000 | -22.5% | 445,667 | +3.4% | 0.12% | -17.9% |
| Q2 2022 | $12,839,000 | +13.4% | 431,061 | +0.2% | 0.14% | +34.3% |
| Q1 2022 | $11,322,000 | +13.6% | 430,296 | +0.4% | 0.11% | +17.4% |
| Q4 2021 | $9,968,000 | -60.6% | 428,578 | -47.8% | 0.09% | -24.6% |
| Q3 2021 | $25,326,000 | +156.6% | 821,094 | +104.1% | 0.12% | +27.1% |
| Q2 2021 | $9,868,000 | +31.2% | 402,349 | -0.1% | 0.10% | +29.7% |
| Q1 2021 | $7,521,000 | -6.6% | 402,793 | -0.2% | 0.07% | -17.8% |
| Q4 2020 | $8,050,000 | +34.5% | 403,634 | +11.8% | 0.09% | +11.1% |
| Q3 2020 | $5,983,000 | +40.7% | 361,061 | +64.9% | 0.08% | +14.1% |
| Q2 2020 | $4,252,000 | +106.1% | 218,932 | +53.1% | 0.07% | +69.0% |
| Q1 2020 | $2,063,000 | – | 143,031 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |